Matinas BioPharma Holdings, Inc.
MTNB
$2.13
$0.3922.41%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.25M | -1.66M | -8.43M | -4.28M | -5.72M |
| Total Depreciation and Amortization | 122.00K | 128.00K | 247.00K | 244.00K | 241.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -18.00K |
| Total Other Non-Cash Items | 3.58M | 21.00K | 4.59M | 968.00K | 972.00K |
| Change in Net Operating Assets | -481.00K | -500.00K | 86.00K | -437.00K | 1.42M |
| Cash from Operations | -2.02M | -2.01M | -3.51M | -3.50M | -3.11M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 500.00K | 9.65M | -2.94M |
| Cash from Investing | -- | -- | 500.00K | 9.65M | -2.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -1.00K | -1.00K | -1.00K | -2.00K | -1.00K |
| Issuance of Common Stock | -- | -- | 0.00 | -- | 9.19M |
| Repurchase of Common Stock | -- | -- | -- | -65.00K | -- |
| Issuance of Preferred Stock | 3.30M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.68M | 1.65M | -- | -- | -- |
| Cash from Financing | 1.62M | 1.65M | -1.00K | -67.00K | 9.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -399.00K | -360.00K | -3.01M | 6.08M | 3.15M |